The stabilities of the antiviral states induced by different types of murine interferons (IFNs) were compared to gain insight into possible differences in the modes of regulation of their respective antiviral states. Both type I (MulFN-e and MuIFN-fl) and type II (MuIFN-?) IFNs were employed to establish antiviral states against mengovirus in mouse L-929 cells. At various times after IFN treatment, the IFNs were removed and the stability of the antiviral states was determined by single cycle mengovirus yield reduction experiments. The antiviral states induced by the two type I IFNs decayed significantly by 12 h following IFN removal. The rate of this decay was an exponential function of the level of the antiviral state induced. A transcriptional block effectively delayed the decay of the antiviral state, suggesting the involvement of a positive feedback mechanism of regulation. In contrast, the profile of the antiviral state induced by type II IFN showed a significant enhancement upon MulFN-~ removal. This enhancement was not dependent upon de novo transcriptional and translational activity of the cells. These data suggest that the modes of regulation of the antiviral states against mengovirus induced by type I and type II IFNs are distinctly different.
INTRODUCTION
Interferons (IFNs) are a class of proteins which were identified initially for their ability to protect homologous cells from virus infection. Three types of IFNs have been recognized: IFNcc and IFN-fl (type I IFNs) and IFN-y (type II IFN) (for review, see Baron et al., 1982) . Studies suggest that the mechanism of induction of the antiviral response by ItaN-~ is different from the mechanisms of induction by IFN-e and by IFN-fl. Dianzani et al. (1980) have shown that the kinetics of the development of an antiviral state induced by IFN-~ are slower than those of IFNa and involve multiple rounds of macromolecular synthesis. Samuel and colleagues (Masters & Samuel, 1983; Ulker & Samuel, 1985) have provided evidence to suggest that the mechanism of IFN-3,-mediated inhibition of vesicular stomatitis virus is different from the mechanism of IFNe-mediated inhibition. Colonno & Pang (1982) have shown that IFN-y induces at least three additional mRNAs not detected in cells treated with IFN-e or IFN-fl. Similarly, IFN-~ has been shown to induce a number of unique proteins in addition to those in common with IFN-~ and IFN-fl (Well et al., 1983) .
This study has focused on the regulation of the antiviral states induced against mengovirus challenge by MuIFN-e and MulFN-fl and by MuIFN-y in mouse L-929 cells. The results indicate that the regulation of the antiviral state induced by MuIFN-e and MuIFN-fl and by MuIFN-7 occurs via distinctly different mechanisms.
v. RAMAMURTHY AND W. R. FLEISCHMANN stock of mengovirus (1092 p.f.u./mt, Franklin isolate) was produced from confluent monolayers of L-929 cells infected with virus at a multiplicity of 0.01 p.f.u./cell, and harvested after 24 h at 37 °C. The virus stock was stored at -70 °C.
lnterferons. MuIFN-~//~ (10 *'5 U/mg protein) was produced in L-929 cells by Newcastle disease virus infection, as described previously (Fleischmann & Simon, 1974) . Partially purified natural MulFN-~ (106.o U/rag protein) and MuIFN-//(107.0 U/mg protein) were purchased from Lee Biomolecular Research Laboratories, San Diego, Ca., U.S.A. MuIFN-~, (103.5 U/mg protein) was produced by stimulating C57BL/6 spleen cells in culture with staphylococcal enterotoxin A (Osborne et al., 1979) . Recombinant DNA-derived MuIFN-~2 (reported to be > 95 pure at 1067 U/mg protein) was kindly provided by Drs Patrick Gray, Gene Burton and Ernst Rinderknecht, Genentech.
RESULTS

Kinetics of development and stability of the antiviral state
The kinetics of the development of the antiviral state were followed by determining the single cycle virus yield in L-929 cells that were exposed to MulFN-~///, MuIFN-% or growth medium for 12, 24, 36 or 48 h and challenged with mengovirus (m.o.i. 10) at the time of IFN removal. In most of the experiments, submaximal IFN concentrations were used to avoid attaining saturation response levels. The decay kinetics were studied by determining the single cycle virus yield in cells challenged with mengovirus at 12 and 24 h after IFN (or medium) removal.
Moderately high virus challenge (m.o.i. 10) was used to attain a single cycle of virus growth, and to prevent multiple cycles of virus replication. This minimized the elapsed time between virus challenge and measurement of virus growth. Moreover, since mengovirus shuts off host metabolism rather rapidly (McCormick & Penman, 1967) , the metabolic decay of the antiviral state should not have a differential impact during the virus replication period. This technique of single cycle virus growth has been used previously by Hallum et al. (1970) to show the rapid rate of decay of the antiviral state against Newcastle disease virus in chick embryo cells.
The developmental kinetics of the antiviral state in MulFN-c~///-treated cells followed a modal curve (Fig. 1 a) , peaking at about 24 h. Further exposure resulted in a decline of the antiviral state. The antiviral state in cells exposed to MulFN-c~///for 12 h appeared to be moderately stable. However, when cells were treated for 24 h or more, the antiviral state showed a remarkable rate of decay following IFN removal.
As shown in Fig. 1 (b) , the kinetics of the development of the antiviral state in MuIFN-?-treated cells were qualitatively similar to those in MuIFN-~//~-treated cells. There was a modal profile of the development of the antiviral state which peaked by 24 to 36 h treatment and declined on further exposure. In contrast to the decay of the MulFN-c~///-induced antiviral state following IFN removal, the MulFN-~-induced antiviral state showed an enhancement. In cells treated with MulFN-~, for 24 h or longer, the antiviral state attained a level almost 1 loglo unit higher than the maximum antiviral state attainable in the presence of MuIFN-7. The enhancement of the antiviral state, however, was transient, peaking around 12 h after IFN removal.
Kinetics of the stability of the antiviral state induced by purified IFNs
The IFNs used in the above experiment were relatively crude preparations. Therefore, partially purified MulFN-c~, MulFN-/~ and essentially pure recombinant MulFN-~ were employed (Fig. 2) . The decay profiles of the antiviral states induced by partially purified MulFN-~ and MulFN-/~ were identical to one another and to that of MulFN-~//~, suggesting that they were similarly regulated. While the possible contribution of contaminants could not be completely ruled out, the fact that both partially purified MulFN-~ and partially purified MulFN-/~ had the same decay profile as crude MulFN-~//~ suggested that the decay profile of the antiviral state was not likely to be affected by contaminants present in the IFN preparations. As a result of these observations, MulFN-~//~ was employed for subsequent studies.
The antiviral states induced by partially purified mitogen-induced MulFN-~ and by essentially pure recombinant DNA-derived MuIFN-~ exhibited similar profiles of enhancement, suggesting that the enhancement was a part of the mode of regulation of the MulFN-~-induced antiviral state, and not due to other substances present in the splenocyte culture fluid. 
Factors influencing the decay of the MulFN-a/ fl-induced antiviral state Initial level of protection
The concentration and duration of the I F N treatment were varied to give a wide range of initial levels of the antiviral states, and the kinetics of the decay of these antiviral states were followed (Fig. 3) . It could be observed that higher initial levels of the antiviral states resulted in a faster rate of decay (steeper curves), while lower initial levels of the antiviral states resulted in a slower rate of decay (shallower curves). This feature is shown more explicitly by plotting the initial levels of the antiviral states against their decay rate (negative slope of the best fitting curve) (Fig. 4) . There was a good correlation between the decay rate and the initial levels of the antiviral states. On the other hand, there was no influence of the duration of I F N treatment on the rate of decay of the antiviral state since both treatment periods afforded similar rates of decay when the initial levels of the antiviral states were similar.
Macromolecular synthesis
To probe the mechanism of the regulation of the MuIFN-a/fl-induced antiviral state, inhibitors of transcription (actinomycin D) and translation (cycloheximide) were used. L-929 cells were incubated in growth medium with or without MuIFN-ct/fl for 24 h. At 24 h, the cultures were washed and treated with medium alone, with actinomycin D (5 ~g/ml for 2 h followed by growth medium) or with cycloheximide (20 ~tg/ml). Previous studies have shown that these treatment regimens reduce R N A and protein synthesis, respectively, by about 9 5~ (Rose et al., 1985) .
As observed before, the antiviral state in IFN-treated cells decayed when followed by incubation in medium alone. However, when cells were treated with actinomycin D to block their transcriptional activity, the antiviral state showed an enhanced level following I F N removal, when compared to the 0 h value, instead of a decay (Fig. 5) . Even though the degree of enhancement was somewhat variable (two-to sixfold), this was a consistent observation. In cells treated with cycloheximide after IFN removal, the decay of the antiviral state was blocked. Moreover, when cycloheximide treatment was limited to 5 h, the cells showed a greater level of enhancement of the antiviral state compared to cells treated with cycloheximide for more than 5 h (until they were infected with virus). These results indicated that the decay of the MulFN-0t/fl-induced antiviral state was abrogated by blocking translational activity in cells. Also, either the regulatory transcripts or the regulatory proteins were turned over at a faster rate than the antiviral proteins. The translational block by cycloheximide is reversible. Since the removal of cycloheximide at 5 h prevented the decay of the antiviral state, we have interpreted the results to suggest that the regulatory transcripts, rather than the regulatory proteins, were unstable. Taken together, these results suggest that the MulFN-ct/fl-induced antiviral state is regulated by a positive feedback mechanism requiring de novo RNA and protein synthesis to counteract the induced antiviral state and that the de novo synthesized counteractive regulatory transcripts have a short half-life.
Factors influencing the enhancement of the MulFN-~-induced antiviral state
Concentration of MulFN-y
The level of enhancement of the antiviral state following removal of MulFN-y in cells treated with different concentrations of MulFN-), was studied to examine the dose responsiveness of the enhancement (Fig. 6) . At the lowest concentration of MuIFN-), tested (12 U/ml), there was no significant enhancement in the level of the antiviral state. At higher MuIFN-7 concentrations, enhancement of the antiviral state occurred. The extent of this enhancement was not proportional to the concentration of MuIFN-~, used. The maximum level of enhancement observed in cells treated with 37 U/ml MulFN-y (about fourfold in this experiment) was not significantly different from the maximum level of enhancement observed in cells treated with higher concentrations of MulFN-~, (1000 U/ml). However, the duration of the enhanced level of the antiviral state was longer in cells treated with higher MulFN-~, concentrations. These results suggest that (i) there is a minimum threshold level of MulFN-~,-induced antiviral state below which the enhancement of the antiviral state following MuIFN-7 removal does not occur, (ii) the maximum attainable level of enhancement is restricted, and (iii) the duration of the maintenance of an enhanced antiviral state is reflective of the concentration of MuIFN-~, used, higher concentrations resulting in longer maintenance of the enhanced antiviral state.
Macromolecular synthesis
The role of macromolecular synthesis in the enhancement of the MuIFN-'f-induced antiviral state was studied by using actinomycin D and cycloheximide (Fig. 7) . Enhancement of the antiviral state following IFN removal was not effectively blocked in actinomycin D-treated or cycloheximide-treated cells, although the absolute level of enhancement observed in cells treated with inhibitors was lower than in cells treated with medium alone. These results suggest that the enhancement of the antiviral state does not require de novo macromolecular synthesis, i.e. the transcripts and/or protein present at the time of IFN removal were sufficient to enhance the antiviral state following MuIFN-~ removal. (Friedman et al., 1984) .
The MuIFN-y-induced antiviral state showed an enhancement upon IFN removal. Levels of antiviral state obtained after IFN removal were not found in the presence of MuIFN-~ (Fig. 1) . Thus, the enhancement of the antiviral state following MuIFN-~ removal could not be explained by the continued induction by residual IFN in the culture fluid. This obviated the t,~e of anti-IFN serum to ensure blocking of a recycling effect. The enhancement of the antiviral state occurred following MulFN-,/ removal even in the absence of additional RNA or protein synthesis (Fig. 7) . To explain this, we propose that MulFN-y may directly induce both antiviral proteins and counteractive molecules. Upon IFN removal, the counteractive regulatory molecules may turn over faster than the antiviral proteins, permitting the expression of an enhanced level of antiviral state.
The data presented here for mengovirus have been confirmed for vaccinia virus (our unpublished observations), suggesting that the differential regulation of the antiviral state following type I (MuIFN-~ and MuIFN-fl) and type II (MuIFN-y) treatment may be a general phenomenon. These studies may provide insights into developing protocols for judicious clinical application of the IFNs, since they suggest that the effects following MuIFN-y treatment may be enhanced and may persist long after IFN levels in the body fluids become undetectable.
